일정
[웨비나] Rapid evaluation of SARS-CoV-2 antibody levels by biolayer interferometry immunosorbent assay [한국시간 2월 10일 1AM]
기간 : 2021-02-10 ~ 2021-02-10
시간 : 01:00:00 ~ 18:00
[ Webinar ]
Rapid evaluation of SARS-CoV-2 antibody levels by biolayer interferometry immunosorbent assay (BLI-ISA)
[ Time ]한국시간 2월 10일 1 AM
[ Presenter ]Rebecca DuBois, Ph.D.
Associate Professor
Department of Biomolecular Engineering, University of California Santa Cruz
Jeremy Petravicz Ph.D.
Editor
Current Protocols
[ Overview ]
Research into detection methods for SARS-CoV-2 antibodies has rapidly accelerated during the pandemic in response to global health needs. In this virtual seminar, Dr. Rebecca DuBois will discuss her latest research investigating SARS-CoV-2 antibodies and describe the development of a novel application of biolayer interferometry for the rapid detection of SARS-CoV-2 antibody levels in plasma. This biolayer interferometry immunosorbent assay (BLI-ISA) utilizes single-use biosensors in an automated “dip-and-read” format, providing real-time optical measurements of antigen loading, plasma antibody binding, and antibody isotype detection, with semi-quantitative results obtained in less than 20 minutes. Dr. DuBois will describe the utility of BLI-ISA for COVID-19 studies, and the potential to develop BLI-ISA as a novel diagnostic platform for infectious diseases.
Who should attend:
- Vaccine development scientists and researchers engaged in the evaluation of antibody responses in animals and humans
- Anyone interested in learning more about converting from ELISA to BLI-ISA to reduce experimental time and increase sensitivity and reproducibility
- Detailed overview of the development of BLI-ISA to measure antigen-specific antibody levels in plasma
- Benefits of rapid and real-time BLI-ISA data collection for developing a customized assay
admin
·
2021-01-25 11:04 ·
조회 258